发明名称 THERAPEUTIC AGENT FOR DIABETES
摘要 <p>A therapeutic agent for diabetes comprising a compound represented by general formula (I) ¢wherein X represents (a), (b) or (c)! ¢wherein R4 and R5, which may be the same or different, represent a hydrogen atom, or an optionally substituted alkyl group having 1 to 5 carbon atoms and R6 represents a hydrogen atom or an amino protective group; R1 represents an optionally substituted alkyl group having 1 to 5 carbon atoms or an optionally substituted alkenyl group having 2 to 6 carbon atoms; R2 represents a hydrogen atom or an optionally substituted alkyl group having 1 to 5 carbon atoms; R2' represents a hydrogen atom; and R3 represents an optionally substituted alkyl group having 1 to 5 carbon atoms!, a prodrug compound thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof, or a solvate thereof. The agent has an excellent blood sugar lowering activity in the case of a high blood sugar level, does not influence the blood sugar in the case of a normal blood sugar level, that is, does not cause any severe side effect, such as hypoglycemia, and is useful not only as a therapeutic agent but also as a prophylactic for chronic complications of diabetes.</p>
申请公布号 CA2246725(A1) 申请公布日期 1997.08.21
申请号 CA19972246725 申请日期 1997.02.17
申请人 JAPAN TOBACCO INC. 发明人 FURUKAWA, NOBORU;SHINKAI, HISASHI;OZEKI, HIDEKAZU
分类号 C07C49/04;C07C49/11;C07C49/297;C07C49/303;C07C49/307;C07C49/313;C07C49/323;C07C49/543;C07C49/563;C07C49/76;C07C49/782;C07C49/784;C07C49/788;C07C49/792;C07C49/794;C07C49/796;C07C49/813;C07C49/82;C07C49/84;C07C49/86;C07C59/205;C07C59/353;C07C59/84;C07C59/86;C07C59/90;C07C62/20;C07C62/22;C07C62/38;C07C69/716;C07C69/738;C07C233/31;C07D207/26;C07D207/27;C07D213/50;C07D307/33;C07D333/24;C07D333/56;(IPC1-7):C07C59/84;A61K31/365;C07C65/36;A61K31/33;C07C49/29;A61K31/215;A61K31/19;A61K31/16;A61K31/12;A61K31/44;A61K31/40;A61K31/38 主分类号 C07C49/04
代理机构 代理人
主权项
地址